The good news is that the corrective action is advancing and opportunities are developing.
The technical indicators suggest that traders should wait until a bottom pattern plays out in the shares of the vaccine maker.
Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.
Let's take the temperature of this important Dow component.
The key question now is whether the biopharmaceutical stock can break out to the upside.
Should investors still sink their teeth into this one?
Shares of the medical device company could retest the lows of December and March.
Let's see what the charts of the pharmacy and health services provider suggest.
The company went public in May. Let's see what the charts tell us.
Why are the healthcare and utilities ETFs not going up now? Let's take a deep dive.
I didn't like it then and I don't like it now.
With two approaches on the same page, here's how we'd trade this drugmaker's stock.
LifeMD had one of the best quarters among my small cap holdings this earnings season -- let's see how to trade the telehealth name.
The advance is looking mature and a shift in strategy may be called for.
Unbelievably, there may be more interest in weight loss than AI right now.
One earnings story that caught my eye was this pharmaceutical name.
Traders and investors should take appropriation action.
Here's how traders can play the stock.
These major high-yield real estate investment trusts deserve a closer look.
This vaccine developer just released strong earnings and here's how I'm using an options play to add to the name.
Buyers of the biopharmaceutical's shares are being more aggressive.
Performance is improving across the firm. The balance sheet and free cash flow are in places we never expected to see a few years ago.
Can the shares overcome a key price area?
Has the key Dow component made a low? Is it a buy? Let's dive in.
Let's look at three iconic names in the healthcare sector that offer solid yields.
While we may start the first half of the week without much action, prepare for an interesting next few weeks during an ordinarily quiet season.
Let's examine the charts to see what traders can do now.
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login